Correlation Between Alnylam Pharmaceuticals and MannKind Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alnylam Pharmaceuticals and MannKind Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alnylam Pharmaceuticals and MannKind Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alnylam Pharmaceuticals and MannKind Corp, you can compare the effects of market volatilities on Alnylam Pharmaceuticals and MannKind Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alnylam Pharmaceuticals with a short position of MannKind Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alnylam Pharmaceuticals and MannKind Corp.

Diversification Opportunities for Alnylam Pharmaceuticals and MannKind Corp

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Alnylam and MannKind is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals and MannKind Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MannKind Corp and Alnylam Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alnylam Pharmaceuticals are associated (or correlated) with MannKind Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MannKind Corp has no effect on the direction of Alnylam Pharmaceuticals i.e., Alnylam Pharmaceuticals and MannKind Corp go up and down completely randomly.

Pair Corralation between Alnylam Pharmaceuticals and MannKind Corp

Given the investment horizon of 90 days Alnylam Pharmaceuticals is expected to under-perform the MannKind Corp. In addition to that, Alnylam Pharmaceuticals is 1.95 times more volatile than MannKind Corp. It trades about -0.19 of its total potential returns per unit of risk. MannKind Corp is currently generating about -0.04 per unit of volatility. If you would invest  682.00  in MannKind Corp on August 28, 2024 and sell it today you would lose (10.00) from holding MannKind Corp or give up 1.47% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Alnylam Pharmaceuticals  vs.  MannKind Corp

 Performance 
       Timeline  
Alnylam Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Alnylam Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
MannKind Corp 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in MannKind Corp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating forward-looking signals, MannKind Corp exhibited solid returns over the last few months and may actually be approaching a breakup point.

Alnylam Pharmaceuticals and MannKind Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alnylam Pharmaceuticals and MannKind Corp

The main advantage of trading using opposite Alnylam Pharmaceuticals and MannKind Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alnylam Pharmaceuticals position performs unexpectedly, MannKind Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MannKind Corp will offset losses from the drop in MannKind Corp's long position.
The idea behind Alnylam Pharmaceuticals and MannKind Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data